Emerging infections and global blood safety

Developments in Biologicals

Volumn 127, Issue , 2007, Pages 237-248

  Dodd, R Y ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Blood transfusion; Emerging infections; Human behavior; International; Safety

Indexed keywords

BIOLOGICAL WARFARE; BLOOD; BLOOD TRANSFUSION; COMMUNICABLE DISEASE; CONFERENCE PAPER; HEALTH; HUMAN;

BIOTERRORISM; BLOOD TRANSFUSION; COMMUNICABLE DISEASES, EMERGING; HUMANS; WORLD HEALTH;

EID: 34247113182     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (30)

1. WHO: Global database on blood safety. Report 2002-2002. http://www.who.int/bloodsafety/GDBS_Report_2001-2002.pdf.
2. Frank C, Mohamed MK, Strickland GT, et al: The role of patenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-891.
3. Dodd RY, Notari EP, Stramer SL: Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42: 975-979.
4. Dodd RY: Current safety of the blood supply in the United States Int J Hematol 2004; 80: 301-305.
5. Mungai M, Tegtmeier G, Chamberland M, Parise M: Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001; 344: 1973-1978.
6. Matsui T, Inoue R, Kajimoto K, et al: First documentation of transfusion-associated babesiosis in Japan [article in Japanese with English summary]. Rinsho Ketsueki 2000; 41: 628-634.
7. Leiby DA, Chung APS, Gill JE, Houghton R L, Persing DH, Badon S, Cable RG: Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti. Transfusion 2005; 45: 1804-1810.
8. Cable RG, Badon S, Trouern-Trend, et al: Evidence for transmission of Babesia microti from Connecticut blood donors to recipients. Transfusion 2001; 41 (Suppl): 12S-13S (Abstr.)
9. Leiby DA, Chung APS, Cable RG, et al: Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors. Transfusion 2002; 42: 1585-1591.
10. Dodd RY, Leiby DA: Emerging infectious threats to the blood supply. Annual Review of Medicine 2004; 55: 191-207.
11. Leiby DA, Herron RM, Read EJ, Lenes BA, Stumpf RJ: Trypanosoma cruzi in Los Angeles and Miami blood donors: Impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002; 42: 549-555.
12. Leiby DA, Lenes BA, Tibbals MA, et al: Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999; 341: 1237-1239.
13. Leiby DA, Fucci MH, Stumpf RJ: Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission. Transfusion 1999; 39: 310-315.
14. CDC: Viscerotropic Leishmaniasis in persons returning from operation Desert Storm - 1990-1991. MMWR 1992; 41: 131-134.
15. Petersen LR, Hayes EB: Westward ho ? - the spread of West Nile virus. N Engl J Med 2004; 351: 2257-2259.
16. Pealer LN, Marfin AA, Petersen LR, et al: Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236-1245.
17. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP Dodd RY: West Nile virus among blood donors in the United States, 2003 and 2004. New Engl J Med 2005; 353: 451-459.
18. Regamey N, Tamm M, Wernli M et al: Transmission of human herpes virus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998; 339: 1358-1363.
19. Cannon MJ, Dollard SC, Smith DK et al: Blood-borne and sexual transmission of human herpes virus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 2001; 344: 637-643.
20. Mbulaiteye SM, Biggar RJ, Bakaki PM et al: Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. J Natl Cancer Inst 2003; 95: 1330-1335.
21. Dollard SC, Nelson KE, Ness PM, et al: Possible transmission of Human herpesvirus 8 by blood transfusion in a historical United States cohort. Transfusion 2005; 45: 500-503.
22. Marra MM, Jones SJM, Astell CR et al: The genome sequence of the SARS-associated coronavirus. Science 2003; 300: 1399-1404.
23. Rota PA, Oberste MA, Monroe SS et al: Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003; 300: 1394-1399.
24. Llewelyn CA, Hewitt PE, Knight RS et al: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-421.
25. Peden AH, Head MW, Ritchie DL et al: Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527-529.
26. Eastlund T, Persing D, Mathiesen D et al: Human granulocytic ehrlichiosis after red cell transfusion (abstract). Transfusion 1999; 39 (Suppl): 117S (Abstr).
27. Boneva RS, Grindon AJ, Orton SL, et al: Simian foamy virus infection in a blood donor. Transfusion 2002; 42: 886-891.
28. CDC: Chagas disease after organ transplantation - United States, 2001. MMWR 2002; 52: 210-212.
29. CDC: Investigation of rabies infections in organ donor and transplant recipients - Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR 2004; 53: 586-589.
30. CDC: Lymphocytic choriomeningitis virus infection in organ transplant recipients - Massachusetts, Rhode Island, 2005. MMWR 2005; 54: 537-539.